Skip to main content
SHPH
NASDAQ Life Sciences

Shuttle Pharmaceuticals Appoints New CFO, Director Resigns

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.41
Mkt Cap
$2.293M
52W Low
$1.26
52W High
$25.25
52W Position info
12% above low
Off High info
94% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

SHPH is trading near its 52-week low of $1.26 (12% above the low).

Summary

Shuttle Pharmaceuticals Holdings, Inc. announced the appointment of Yuying Liang as its new Chief Financial Officer, while current Interim CEO Chris Cooper steps down from the CFO role. Concurrently, director Sachin Pathigoda resigned from the board.


Key Events · Executive and Board Changes · SHPH

  • New Chief Financial Officer Appointed

    Yuying Liang, CPA, was appointed Chief Financial Officer, effective January 6, 2026.

  • Interim CEO Focuses on Leadership Role

    Chris Cooper, previously Interim CEO and CFO, will now solely serve as Interim Chief Executive Officer.

  • Significant CFO Compensation

    Ms. Liang's professional corporation will receive a monthly fee of $15,000 for services, representing a substantial expense for the company.

  • CFO Holds Multiple Concurrent Roles

    Ms. Liang currently serves as Chief Financial Officer for several other public and private companies.


Analysis · SHPH · Life Sciences

The appointment of Ms. Yuying Liang as Chief Financial Officer is a significant executive change for this micro-cap company. While bringing extensive experience, her engagement through a professional corporation at a monthly fee of $15,000 represents a substantial annual financial commitment relative to the company's small market capitalization. Furthermore, Ms. Liang's concurrent CFO roles at multiple other public companies may raise questions regarding her dedicated time and focus. The resignation of director Sachin Pathigoda, though stated as not due to disagreement, adds to the changes in the company's governance structure. Investors should monitor the impact of these executive and board changes on the company's operations and financial management.

At the time of this filing, SHPH was trading at $1.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $1.26 to $25.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SHPH - Latest Insights

SHPH
Jul 13, 2026, 2:34 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.99
Real-time Price: $2.80 info
Change: -$0.190 (-6%) info
Market Cap: $1.841M info
SHPH
Jul 01, 2026, 7:17 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.28
Real-time Price: $2.80 info
Change: -$0.4769 (-15%) info
Market Cap: $1.841M info
SHPH
Jul 01, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.03
Real-time Price: $2.80 info
Change: -$0.230 (-8%) info
Market Cap: $1.841M info
SHPH
Jun 30, 2026, 7:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.03
Real-time Price: $2.80 info
Change: -$0.230 (-8%) info
Market Cap: $1.841M info
SHPH
Jun 25, 2026, 4:05 PM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $3.78
Real-time Price: $2.80 info
Change: -$0.980 (-26%) info
Market Cap: $1.841M info